Yuhao Qin, n/a (he/him/his)

Jiangsu Hengrui Pharmaceuticals Co., Ltd
Shanghai, China (People's Republic)

Presentation(s):

• 0915: A Fusion of TACI Variant and Anti-ifnar Antibody with Greater Therapeutic Effect on Related Autoimmune Disease Models

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.